Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

Hemoglobin H-constant spring in North America: an alpha thalassemia with frequent complications.

  • Read more about Hemoglobin H-constant spring in North America: an alpha thalassemia with frequent complications.

HLA type and risk of alloimmunization in sickle cell disease.

  • Read more about HLA type and risk of alloimmunization in sickle cell disease.

Hydroxycarbamide-induced changes in E/beta thalassemia red blood cells.

  • Read more about Hydroxycarbamide-induced changes in E/beta thalassemia red blood cells.

Clinical application of deferasirox: practical patient management.

  • Read more about Clinical application of deferasirox: practical patient management.

Pyrimethamine treatment does not ameliorate lymphoproliferation or autoimmune disease in MRL/lpr-/- mice or in patients with autoimmune lymphoproliferative syndrome.

  • Read more about Pyrimethamine treatment does not ameliorate lymphoproliferation or autoimmune disease in MRL/lpr-/- mice or in patients with autoimmune lymphoproliferative syndrome.

Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload.

  • Read more about Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload.

Pulmonary hypertension in thalassemia: association with platelet activation and hypercoagulable state.

  • Read more about Pulmonary hypertension in thalassemia: association with platelet activation and hypercoagulable state.

Fluorodeoxyglucose positron emission tomography (FDG-PET) for monitoring lymphadenopathy in the autoimmune lymphoproliferative syndrome (ALPS).

  • Read more about Fluorodeoxyglucose positron emission tomography (FDG-PET) for monitoring lymphadenopathy in the autoimmune lymphoproliferative syndrome (ALPS).

Comparison of organ dysfunction in transfused patients with SCD or beta thalassemia.

  • Read more about Comparison of organ dysfunction in transfused patients with SCD or beta thalassemia.

Central venous catheter complications in sickle cell disease.

  • Read more about Central venous catheter complications in sickle cell disease.

Pagination

  • Previous page ‹‹
  • Page 4
  • Next page ››
Subscribe to American journal of hematology

Pediatrics Home

MAKE A GIFT

© 2022 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                              Accessibility  Privacy Policy  Terms of Use  A-Z Website List